Meanwhile, YHLO held the European Partner Meeting here in Athens, inviting our partners and friends from more than 10 countries. YHLO has made in-depth discussions on important topics of market dynamics, business strategies, and future directions. Our European partners also shared their experiences, gains and challenges. YHLO greatly appreciates all partners’ efforts and will keep providing professional products and improving market service.

YHLO is one of the few manufacturers in the industry that can provide unique tests for autoimmunity, developed more than 40 CLIA products for autoimmune diseases such as autoimmune diabetes, antiphospholipid syndrome, rheumatoid arthritis, etc. YHLO has also achieved fruitful academic achievements in areas such as SARS-Cov-2, self-immunization, reproductive health, and diabetes. YHLO will always keep on building a benchmark brand in the IVD industry with our constantly-improving service and products.